FRI0277 Cardiovascular risk assessment in patients with ankylosing spondilytis: Comparison of three indexes and related variables

Background EULAR task force recommendations in the cardiovascular (CV) risk were published in 2010. EULAR recommends the use of the SCORE when no local guidelines are available. In our country, two charts have been calibrated and are widely used to calculate cardiovascular mortality at 10 years, the SCORE table, calibrated by the National Cardiology Society (cSCORE) and the Framingham-Wilson score (REGICOR). Objectives To assess the CV risk in Ankylosing Spondilytis (AS) patients (pts) using the SCORE for low risk European countries (eSCORE) and compare it with the cSCORE and the REGICOR. Furthermore, we analyzed the correlation of several clinical and serological variables with these indexes, and the percentage of high and very high CV risk pts receiving an adequate therapy for its management, coxibs and/or NSAIDs. Methods This cross-sectional study included 103 consecutive pts who fulfilled the modified New York criteria for AS followed in our outpatient clinics. Patients with a previous CV event and diabetics were excluded. The following data were recorded for logistic regression analysis: sex, age, body mass index, classic CV risk factors, lipid profile, duration in months since diagnosis, clinical patterns of the AS, treatment, and inflammatory markers (p